Carlos Caldas

62PUBLICATIONS
588CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyEpigenetics (incl. genome methylation and epigenomics)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (62)

|Feb 03, 2026
PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

Rosie A B Voorthuis, Mafalda Oliveira, Annelot G J van Rossum

|Jan 06, 2026
Evaluating progesterone receptor agonist megestrol plus letrozole for women with early-stage estrogen-receptor-positive breast cancer: the window-of-opportunity, randomized, phase 2b, PIONEER trial.

Rebecca A Burrell, Sanjeev Kumar, Elena Provenzano

|Apr 22, 2025
Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse.

Diana Drago-Garcia, Suvendu Giri, Rishita Chatterjee

|Apr 22, 2025
Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data.

Rong Zhu, Katherine Eason, Suet-Feung Chin

|Apr 15, 2025
A large-scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression-free survival.

Emma J Beddowes, Mario Ortega Duran, Solon Karapanagiotis

|Mar 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Wolfgang Janni, Thomas W P Friedl, Tracy C Yab

Pageof 11

Frequent Collaborators

18 joint publications

Oscar M Rueda

16 joint publications

Suet-Feung Chin

6 joint publications

Elena Provenzano

6 joint publications

Violeta Serra